News & Press Releases
Check the latest Sapio news and announcements.
Sapio Sciences Wins Generative AI Innovation Award
BioTech Breakthrough Awards 2025 Recognize Life Sciences & Biotechnology Innovation Around the World
BALTIMORE, MD, November 19, 2025 — Sapio Sciences, the science-awareTM AI lab informatics platform, today announced that Sapio ELaiN has been named the winner of the Generative AI Innovation Award in the fifth annual BioTech Breakthrough Awards.
Sapio ELaiN is the world’s first third-generation Electronic Lab Notebook (ELN), an AI Laboratory Notebook (AILN) that applies generative and agentic AI to scientific research. Built as an AI-native lab notebook, ELaiN functions as a context-aware co-scientist that helps researchers plan, design, and analyze experiments while maintaining scientific rigor and compliance.
“Our vision for ELaiN was never to just improve documentation. It was to remove barriers between intent and execution,” said Mike Hampton, Chief Commercial Officer at Sapio Sciences. “With ELaiN, we’ve created an AI-native platform that acts as a co-scientist, understanding what a researcher wants to do and helping them move through it faster. By embedding AI directly into the workflow, ELaiN accelerates pipelines and expands the space of what is scientifically possible.”
Sapio ELaiN transforms the traditional ELN from a passive system of record into an active participant in scientific discovery. Scientists use natural language prompts to ask questions, initiate actions, generate analyses, and more. Fully integrated with Sapio’s Lab Informatics Platform, which includes LIMS and Scientific Data Cloud, ELaiN can access experimental data, assay results, inventory, and institutional knowledge across drug discovery workflows. This integration allows it not only to answer scientific questions but to execute tasks and generate outputs within the same environment.
Advanced AI-powered capabilities
ELaiN introduces advanced AI agents directly into the notebook, providing scientists with sophisticated functionality without leaving their workflow. Key capabilities include:
- Molecular docking simulation: Perform binding simulations between compounds and targets to accelerate lead identification and optimization.
- Ad hoc data analytics: Instantly analyze and visualize complex data tables to uncover trends and insights.
- Codon optimization: Automatically optimize genetic sequences for expression across different systems.
- Small molecule analysis: Plan retrosynthesis routes, predict toxicity and solubility, and assess compound buyability with AI-powered chemistry tools.
- Protocol-based experimentation: Build and execute experiments directly from text-based protocol descriptions with AI assistance for setup, optimization, and troubleshooting.
- Flow cytometry analysis: Track cell populations, analyze fluorescence intensities, and generate graphical representations of results.
- Knowledge graph and analytics: Integrate structured and unstructured data to discover relationships across experiments.
- Compliance and traceability: Built natively on the Sapio platform, ELaiN operates within the same audit, security, and data provenance frameworks trusted across biopharma R&D.
The biotechnology sector is evolving rapidly as AI, automation, and data-centric tools reshape the life sciences. Generative and agentic AI are driving this transformation by connecting scientific insight with experimental action. Sapio ELaiN embodies this shift, giving scientists an intelligent partner that works alongside them to accelerate discovery and improve decision-making.
“Sapio’s ELaiN is redefining how biotechnology organizations accelerate discovery and decision-making,” said Bryan Vaughn, Managing Director of BioTech Breakthrough. “By embedding generative and agentic AI into everyday research, Sapio enables scientists to plan, design, and analyze experiments with an intelligent co-scientist at their side.”
Now in its fifth year, the BioTech Breakthrough Awards received thousands of nominations from more than 15 countries, recognizing bold ideas shaping the future of biotechnology. Winners are selected for innovation, performance, and potential to advance scientific progress globally.
Learn more about Sapio ELaiN and the future of ELNs: https://www.sapiosciences.com/products/electronic-lab-notebook/
About Sapio Sciences
At Sapio Sciences, our mission is to improve lives by accelerating the entire drug lifecycle. Our configurable, AI-native informatics platform – including LIMS, Sapio ELaiN (3rd Generation ELN), and Scientific Data Cloud – streamlines complex workflows, unifies scientific data, and enables faster, smarter decisions across biopharma research and development, clinical diagnostics, and manufacturing.
Trusted by global leaders and innovators worldwide, we support a wide range of best-in-class applications, from NGS and bioanalysis to bioprocessing, stability studies, histopathology, antibody discovery, and in vivo studies.
Discover how Sapio Sciences can revolutionize your lab operations at www.sapiosciences.com and follow us on LinkedIn.
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughAwards.com
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
Media Inquiries
Tim Brook, Sapio Sciences